These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1168 related items for PubMed ID: 6406157
1. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women. Gaspard UJ, Deville JL, Dubois M. Curr Med Res Opin; 1983; 8(6):395-404. PubMed ID: 6406157 [Abstract] [Full Text] [Related]
2. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles. Bannemerschult R, Hanker JP, Wünsch C, Fox P, Albring M, Brill K. Contraception; 1997 Nov; 56(5):285-90. PubMed ID: 9437556 [Abstract] [Full Text] [Related]
3. Clinical experience with a triphasic oral contraceptive. Ulstein M, Svendsen E, Steier A, Bratt H, Fylling P, Lie S, Schiefloe A, Aaserud J. Acta Obstet Gynecol Scand; 1984 Nov; 63(3):233-6. PubMed ID: 6428157 [Abstract] [Full Text] [Related]
4. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance. Endrikat J, Müller U, Düsterberg B. Contraception; 1997 Mar; 55(3):131-7. PubMed ID: 9115000 [Abstract] [Full Text] [Related]
5. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age. Kirkman RJ, Pedersen JH, Fioretti P, Roberts HE. Contraception; 1994 Jan; 49(1):33-46. PubMed ID: 8137624 [Abstract] [Full Text] [Related]
6. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version. Carlborg L. Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925 [Abstract] [Full Text] [Related]
7. Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agent. Andolsek KM. Acta Obstet Gynecol Scand Suppl; 1992 May; 156():22-6. PubMed ID: 1324553 [Abstract] [Full Text] [Related]
8. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives. Hamerlynck JV, Vollebregt JA, Doornebos CM, Muntendam P. Contraception; 1987 Mar; 35(3):199-205. PubMed ID: 2956054 [Abstract] [Full Text] [Related]
9. A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives. Dunson TR, McLaurin VL, Aguayo EL, de Silva P, Calventi V, Gerais AS, Serani RG. Contraception; 1993 Jun; 47(6):515-25. PubMed ID: 8334888 [Abstract] [Full Text] [Related]
10. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women. Koetsawang S, Charoenvisal C, Banharnsupawat L, Singhakovin S, Kaewsuk O, Punnahitanont S. Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587 [Abstract] [Full Text] [Related]
11. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception. Russowsky M, Sartoretto JN. Contraception; 1982 Jul; 26(1):41-9. PubMed ID: 7128133 [Abstract] [Full Text] [Related]
12. Clinical tolerance of a combined monophasic contraceptive agent containing a low-dose of ethinyloestradiol and gestodene in adolescents. Leonard F, Gaspard U, Theunissen L. Curr Med Res Opin; 1993 Jul; 13(2):78-86. PubMed ID: 8325045 [Abstract] [Full Text] [Related]
14. A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study. Masson S, Franssen E, Hilditch JR, Powell MG. Contraception; 1993 Jan; 47(1):43-54. PubMed ID: 8436001 [Abstract] [Full Text] [Related]
15. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel. Rekers H. Acta Obstet Gynecol Scand; 1988 Jan; 67(2):171-4. PubMed ID: 2972160 [Abstract] [Full Text] [Related]
16. Long-term experience with a low-dose oral contraceptive. Brill K, Schnitker J, Albring M. Gynecol Endocrinol; 1990 Dec; 4(4):277-86. PubMed ID: 2150581 [Abstract] [Full Text] [Related]
17. Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination. Cullberg G, Samsioe G, Andersen RF, Bredesgaard P, Andersen NB, Ernerot H, Fanøe E, Fylling P, Haack-Sørensen PE, Klottrup P, Pedersen JH, Sandager T. Contraception; 1982 Sep; 26(3):229-43. PubMed ID: 6217028 [Abstract] [Full Text] [Related]
18. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol. Akerlund M, Røde A, Westergaard J. Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004 [Abstract] [Full Text] [Related]
19. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial. Schilling LH, Bolding OT, Chenault CB, Chong AP, Fleury F, Forrest K, Glick HI, Hasson HM, Heil CG, London RS. Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451 [Abstract] [Full Text] [Related]
20. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive. Woutersz TB, Korba VD. Int J Fertil; 1988 May; 33(6):406-10. PubMed ID: 2906915 [Abstract] [Full Text] [Related] Page: [Next] [New Search]